维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Ingiliz"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Applicability and variability of liver stiffness measurements according to probe position显示文摘AIM: To investigate the liver stiffness measurement (LSM) applicability and variability with reference to three probe positions according to the region of liver biopsy. METHODS: The applicability for LSM was defined as at least 10 valid measurements with a success rate greater than 60% and an interquartile range/median LSM < 30%. The LSM variability compared the inter-position concordance and the concordance with FibroTest. RESULTS: Four hundred and forty two consecutive patients were included. The applicability of the anterior position (81%) was significantly higher than that of the reference (69%) and lower positions (68%), (both P = 0.0001). There was a signif icant difference (0.5 kPa, 95% CI 0.13-0.89; P < 0.0001) between mean LSM estimated at the reference position (9.3 kPa) vs the anterior position (8.8 kPa). Discordance between positions was associated with thoracic fold (P = 0.008). The discordance rate between the reference position result and FibroTest was higher when the 7.1 kPa cutoff was used to define advanced fibrosis instead of 8.8 kPa (33.6% vs 23.5%, P = 0.03).CONCLUSION: The anterior position of the probe should be the fi rst choice for LSM using Fibroscan, as it has a higher applicability without higher variability compared to the usual liver biopsy position.	Patrick Ingiliz Kim Pav Chhay Mona Munteanu Pascal Lebray Yen Ngo Dominique Roulot Yves Benhamou Dominique Thabut Vlad Ratziu Thierry Poynard	2009	World Journal of Gastroenterology2009，15，27：	5
	2	HIV ‐ HCV co‐infection facing HCV protease inhibitor licensing: implications for clinicians显示文摘	Patrick Ingiliz Jürgen K. Rockstroh	2012	Liver Int2012，，8：	1
	3	Assessment of liver fibrosis: non- invasive means 显示文摘	Poynard T Morra R Ingiliz P	2008	Saudi J Gastroenterol2008，14，4：	1
	4	Efficacy and safety of adefnvir dipivoxil plus pegylated interfer-on-alpha-2a for the treatment of lamivudine resistant hepatitis B virus infection in HIV-infected patients显示文摘	INGILIZ P VALANTIN M A THIBAUH V		0，，：	1
	5	Assessment of liver fibrosis:noninvasive means显示文摘	Poynard T Morra R Ingiliz P		0，，：	1
	6	Assessment of liver fi- brosis : noninvasive means 显示文摘	Poynard T Morra R Ingiliz P	2008	Saudi J Gastroenterol2008，14，：	1
	7	Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients显示文摘	Ingiliz P Valantin MA Thibault V	2008	Antivir Ther2008，13，7：	1
	8	Assessment of liver fibrosis:noninvasive means显示文摘	Poynard T Morra R Ingiliz P		0，，：	1
	9	P0835 : German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV/HCV co-infected patients (GECOSO)显示文摘	P. Ingiliz S. Christensen D. Hueppe T. Lutz K. Schewe C. Boesecke K.G. Simon G. Schmutz A. Baumgarten H. Busch S. Mauss	2015	Journal of Hepatology2015，，：	1
	10	P0772 : Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: Interim results of a multicenter compassionate use program显示文摘	T.M. Welzel K. Herzer P. Ferenci J. Petersen M. Gschwantler M. Cornberg T. Berg U. Spengler O. Weiland M. Van der Valk H. Klinker J. Rockstroh P. Ingiliz M. Peck-Radosavljevic M.J. Jimenez-Exposito S. Zeuzem	2015	Journal of Hepatology2015，，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费